HWN Suggests

Conducting Pediatric Studies: Addressing Ethical and Clinical Challenges

Children are not simply small adults. From a clinical perspective, there is a significant need for pediatric studies since the physiological, developmental, psychological, and pharmacological characteristics of children vary from those of adults. Children may metabolize medications differently, resulting in sub-optimal therapy, unexpected responses, adverse drug reactions, and toxicity. Importantly, these characteristics also vary among children of different ages and cognitive abilities and may change as they grow from infancy towards adolescence and adulthood.

read full article

Featured

  FindMeCure

Future treatments are now one step closer. Find and join a clinical trial near you!

 ClinicalTrials.gov

ClinicalTrials.gov is a place to learn about clinical studies from around the world.

Articles of Interest

Advancing the development of safe and effective therapies for children

There’s much more to pediatric research than just operating clinical trials. Like you, we’re committed to taking extraordinary measures to improve the lives of children and help their families navigate a time of great uncertainty. Our patient-centric digital and decentralized solutions are designed to not only ensure study effectiveness, but to also remove barriers that families can face when trying to access and participate in pediatric clinical trials.

Clinical trials in children

The mission of the WHO International Clinical Trials Registry Platform is to ensure that a complete view of research is accessible to all those involved in health care decision making. This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base. The aim of the site is to improve awareness and make it easier to access accurate, up to date, understandable information relevant to the conduct of clinical trials in children. It will thereby contribute to addressing the Millennium Development Goal of reducing child mortality.

Clinical trials in children: Is there racial equity?

The treatments and interventions used in medicine are often based on the results of clinical trials. But trials involving adults haven’t always represented the population as a whole, tending to recruit mostly white middle-class people. As a result, it’s not clear how well the findings apply to people of other racial and ethnic backgrounds. Do clinical trials in children have a similar limitation?

Dissemination of the Results of Pediatric Clinical Trials Funded by the US National Institutes of Health

Pediatric research in the US relies predominantly on funding from the National Institutes of Health (NIH), although only 13% of its 2021 budget was allocated to pediatric research.

The state and future of pediatric research—an introductory overview

Pediatric drug and device development continues to lag behind programs addressing adult conditions. Industry-sponsored trials involving children remain limited due to expected lower profitability. Heightened regulatory, ethical, and safety standards for clinical trials involving pregnant women and children, and issues with obtaining parental informed consent and child assent highlight the considerable challenges.

Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019

Clinical trials are considered as the gold standard for assessing the safety and effectiveness of new therapies as well as generating evidence-based knowledge in medicine [1]. However, because of the homogeneity of pediatric population, safety concerns, strict ethical requirements and lack of commercial interest, most of the adult researches cannot be directly generalized to the pediatric population

What You Need to Know if Your Child Participates in a Clinical Trial

Clinical trials can provide access to some of the most up-to-date science available. In some instances, a trial may not result in a direct benefit to your child but may provide information to help treat children with the same disease in the future. The decision to participate in a clinical trial is up to you and your child’s doctor and will be based on your child’s unique needs.

Resources

Pediatric Trials Network

The Pediatric Trials Network (PTN) is studying the formulation, dosing, efficacy, and safety of drugs, as well as the development of medical devices, used in pediatric patients. Children are not simply “little adults” who respond to drugs according to scale. Rather, developing organs and changes in metabolism throughout infancy and childhood affect how drugs are processed by immature or maturing bodies. Thus, special care must be taken in tailoring the use of medicines in this unique and vulnerable population.

Eunice Kennedy Shriver National Institute of Child Health and Human Development

ClinicalTrials.gov also lists all clinical trials sponsored or funded by the federal government, including BPCA-related trials, in addition to trials managed by pharmaceutical companies, academic medical centers, voluntary groups, and other organizations.

Medpace

Medpace has built an experience base in the management of pediatric clinical trials throughout our 30 year history. Sponsors from emerging biotechs to global pharmaceutical companies trust Medpace to lead their pediatric clinical development across a wide range of therapeutic areas, including infectious diseases, type 2 diabetes, familial hypercholesterolemia, and neuroblastoma.

TrialHub

Some pursue relentless growth; we believe in enduring success grounded in authenticity. It’s not about the numbers; it’s about the very human stories that intersect with our mission. Our progress is a testament to a principle we hold dear: a business can flourish when it is built with heart, grounded in empathy, and guided by genuine need. That’s why we’ve created an ecosystem uniting data, medical professionals and AI, for the empowerment of the clinical trials of tomorrow.